Literature DB >> 35819255

BRCA1-Dependent and Independent Recruitment of PALB2-BRCA2-RAD51 in the DNA Damage Response and Cancer.

Tzeh Keong Foo1, Bing Xia1.   

Abstract

The BRCA1-PALB2-BRCA2 axis plays essential roles in the cellular response to DNA double-strand breaks (DSB), maintenance of genome integrity, and suppression of cancer development. Upon DNA damage, BRCA1 is recruited to DSBs, where it facilitates end resection and recruits PALB2 and its associated BRCA2 to load the central recombination enzyme RAD51 to initiate homologous recombination (HR) repair. In recent years, several BRCA1-independent mechanisms of PALB2 recruitment have also been reported. Collectively, these available data illustrate a series of hierarchical, context-dependent, and cooperating mechanisms of PALB2 recruitment that is critical for HR and therapy response either in the presence or absence of BRCA1. Here, we review these BRCA1-dependent and independent mechanisms and their importance in DSB repair, cancer development, and therapy. As BRCA1-mutant cancer cells regain HR function, for which PALB2 is generally required, and become resistant to targeted therapies, such as PARP inhibitors, targeting BRCA1-independent mechanisms of PALB2 recruitment represents a potential new avenue to improve treatment of BRCA1-mutant tumors. ©2022 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35819255      PMCID: PMC9481714          DOI: 10.1158/0008-5472.CAN-22-1535

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   13.312


  67 in total

1.  MRG15 binds directly to PALB2 and stimulates homology-directed repair of chromosomal breaks.

Authors:  Tomohiro Hayakawa; Fan Zhang; Noriyo Hayakawa; Yasuko Ohtani; Kaori Shinmyozu; Jun-ichi Nakayama; Paul R Andreassen
Journal:  J Cell Sci       Date:  2010-04-01       Impact factor: 5.285

2.  RNF168 binds and amplifies ubiquitin conjugates on damaged chromosomes to allow accumulation of repair proteins.

Authors:  Carsten Doil; Niels Mailand; Simon Bekker-Jensen; Patrice Menard; Dorthe Helena Larsen; Rainer Pepperkok; Jan Ellenberg; Stephanie Panier; Daniel Durocher; Jiri Bartek; Jiri Lukas; Claudia Lukas
Journal:  Cell       Date:  2009-02-06       Impact factor: 41.582

3.  MRG15 is a novel PALB2-interacting factor involved in homologous recombination.

Authors:  Shirley M-H Sy; Michael S Y Huen; Junjie Chen
Journal:  J Biol Chem       Date:  2009-06-24       Impact factor: 5.157

4.  The Fanconi Anemia Pathway in Cancer.

Authors:  Joshi Niraj; Anniina Färkkilä; Alan D D'Andrea
Journal:  Annu Rev Cancer Biol       Date:  2018-12-03

5.  Loss of the BRCA1-PALB2 interaction accelerates p53-associated tumor development in mice.

Authors:  Amar H Mahdi; Yanying Huo; Ying Chen; Pier Selenica; Anchal Sharma; Elise Merritt; Nicola Barnard; Chang Chan; Shridar Ganesan; Jorge S Reis-Filho; Britta Weigelt; Subhajyoti De; Bing Xia
Journal:  Genes Dis       Date:  2020-09-05

6.  Enhancement of RAD51 recombinase activity by the tumor suppressor PALB2.

Authors:  Eloïse Dray; Julia Etchin; Claudia Wiese; Dorina Saro; Gareth J Williams; Michal Hammel; Xiong Yu; Vitold E Galkin; Dongqing Liu; Miaw-Sheue Tsai; Shirley M-H Sy; David Schild; Edward Egelman; Junjie Chen; Patrick Sung
Journal:  Nat Struct Mol Biol       Date:  2010-09-26       Impact factor: 15.369

7.  Cancer Risks Associated With Germline PALB2 Pathogenic Variants: An International Study of 524 Families.

Authors:  Xin Yang; Goska Leslie; Alicja Doroszuk; Sandra Schneider; Jamie Allen; Brennan Decker; Alison M Dunning; James Redman; James Scarth; Inga Plaskocinska; Craig Luccarini; Mitul Shah; Karen Pooley; Leila Dorling; Andrew Lee; Muriel A Adank; Julian Adlard; Kristiina Aittomäki; Irene L Andrulis; Peter Ang; Julian Barwell; Jonine L Bernstein; Kristie Bobolis; Åke Borg; Carl Blomqvist; Kathleen B M Claes; Patrick Concannon; Adeline Cuggia; Julie O Culver; Francesca Damiola; Antoine de Pauw; Orland Diez; Jill S Dolinsky; Susan M Domchek; Christoph Engel; D Gareth Evans; Florentia Fostira; Judy Garber; Lisa Golmard; Ellen L Goode; Stephen B Gruber; Eric Hahnen; Christopher Hake; Tuomas Heikkinen; Judith E Hurley; Ramunas Janavicius; Zdenek Kleibl; Petra Kleiblova; Irene Konstantopoulou; Anders Kvist; Holly Laduca; Ann S G Lee; Fabienne Lesueur; Eamonn R Maher; Arto Mannermaa; Siranoush Manoukian; Rachel McFarland; Wendy McKinnon; Alfons Meindl; Kelly Metcalfe; Nur Aishah Mohd Taib; Jukka Moilanen; Katherine L Nathanson; Susan Neuhausen; Pei Sze Ng; Tu Nguyen-Dumont; Sarah M Nielsen; Florian Obermair; Kenneth Offit; Olufunmilayo I Olopade; Laura Ottini; Judith Penkert; Katri Pylkäs; Paolo Radice; Susan J Ramus; Vilius Rudaitis; Lucy Side; Rachel Silva-Smith; Valentina Silvestri; Anne-Bine Skytte; Thomas Slavin; Jana Soukupova; Carlo Tondini; Alison H Trainer; Gary Unzeitig; Lydia Usha; Thomas van Overeem Hansen; James Whitworth; Marie Wood; Cheng Har Yip; Sook-Yee Yoon; Amal Yussuf; George Zogopoulos; David Goldgar; John L Hopper; Georgia Chenevix-Trench; Paul Pharoah; Sophia H L George; Judith Balmaña; Claude Houdayer; Paul James; Zaki El-Haffaf; Hans Ehrencrona; Marketa Janatova; Paolo Peterlongo; Heli Nevanlinna; Rita Schmutzler; Soo-Hwang Teo; Mark Robson; Tuya Pal; Fergus Couch; Jeffrey N Weitzel; Aaron Elliott; Melissa Southey; Robert Winqvist; Douglas F Easton; William D Foulkes; Antonis C Antoniou; Marc Tischkowitz
Journal:  J Clin Oncol       Date:  2019-12-16       Impact factor: 44.544

8.  Phosphorylated RPA recruits PALB2 to stalled DNA replication forks to facilitate fork recovery.

Authors:  Anar K Murphy; Michael Fitzgerald; Teresa Ro; Jee Hyun Kim; Ariana I Rabinowitsch; Dipanjan Chowdhury; Carl L Schildkraut; James A Borowiec
Journal:  J Cell Biol       Date:  2014-08-11       Impact factor: 10.539

9.  PALB2 connects BRCA1 and BRCA2 in the G2/M checkpoint response.

Authors:  Srilatha Simhadri; Gabriele Vincelli; Yanying Huo; Sarah Misenko; Tzeh Keong Foo; Johanna Ahlskog; Claus S Sørensen; Gregory G Oakley; Shridar Ganesan; Samuel F Bunting; Bing Xia
Journal:  Oncogene       Date:  2018-10-18       Impact factor: 9.867

10.  Functional characterization of 84 PALB2 variants of uncertain significance.

Authors:  Timothy Wiltshire; Mandy Ducy; Tzeh Keong Foo; Chunling Hu; Kun Y Lee; Anil Belur Nagaraj; Amélie Rodrigue; Thiago T Gomes; Jacques Simard; Alvaro N A Monteiro; Bing Xia; Marcelo A Carvalho; Jean-Yves Masson; Fergus J Couch
Journal:  Genet Med       Date:  2019-10-21       Impact factor: 8.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.